These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 3606636)
1. New analogues of benzylacyclouridines, specific and potent inhibitors of uridine phosphorylase from human and mouse livers. Naguib FN; el Kouni MH; Chu SH; Cha S Biochem Pharmacol; 1987 Jul; 36(13):2195-201. PubMed ID: 3606636 [TBL] [Abstract][Full Text] [Related]
2. Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases: implications for chemotherapy with 5-fluoropyrimidines. el Kouni MH; el Kouni MM; Naguib FN Cancer Res; 1993 Aug; 53(16):3687-93. PubMed ID: 8339277 [TBL] [Abstract][Full Text] [Related]
3. Effect of the N-glycosidic bond conformation and modifications in the pentose moiety on the binding of nucleoside ligands to uridine phosphorylase. el Kouni MH; Naguib FN; Chu SH; Cha SM; Ueda T; Gosselin G; Imbach JL; Shealy YF; Otter BA Mol Pharmacol; 1988 Aug; 34(2):104-10. PubMed ID: 3412318 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of uridine phosphorylase from Escherichia coli by benzylacyclouridines. Park KS; el Kouni MH; Krenitsky TA; Chu SH; Cha S Biochem Pharmacol; 1986 Nov; 35(21):3853-5. PubMed ID: 3535805 [TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship of ligands of the pyrimidine nucleoside phosphorylases. Niedzwicki JG; el Kouni MH; Chu SH; Cha S Biochem Pharmacol; 1983 Feb; 32(3):399-415. PubMed ID: 6847695 [TBL] [Abstract][Full Text] [Related]
6. Effects of modifications in the pentose moiety and conformational changes on the binding of nucleoside ligands to uridine phosphorylase from Toxoplasma gondii. el Kouni MH; Naguib FN; Panzica RP; Otter BA; Chu SH; Gosselin G; Chu CK; Schinazi RF; Shealy YF; Goudgaon N; Ozerov AA; Ueda T; Iltzsch MH Biochem Pharmacol; 1996 Jun; 51(12):1687-700. PubMed ID: 8687484 [TBL] [Abstract][Full Text] [Related]
7. 5-phenylthioacyclouridine: a potent and specific inhibitor of uridine phosphorylase. el Kouni MH; Goudgaon NM; Rafeeq M; Al Safarjalani ON; Schinazi RF; Naguib FN Biochem Pharmacol; 2000 Sep; 60(6):851-6. PubMed ID: 10930540 [TBL] [Abstract][Full Text] [Related]
8. 5-benzylacyclouridine and 5-benzyloxybenzylacyclouridine, potent inhibitors of uridine phosphorylase. Niedzwicki JG; Chu SH; el Kouni MH; Rowe EC; Cha S Biochem Pharmacol; 1982 May; 31(10):1857-61. PubMed ID: 7104017 [TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship of nucleobase ligands of uridine phosphorylase from Toxoplasma gondii. Iltzsch MH; Klenk EE Biochem Pharmacol; 1993 Nov; 46(10):1849-58. PubMed ID: 8250971 [TBL] [Abstract][Full Text] [Related]
10. Development of inhibitors of pyrimidine metabolism. Cha SM Yonsei Med J; 1989 Dec; 30(4):315-26. PubMed ID: 2697111 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of nucleoside transport in murine lymphoma L5178Y cells and human erythrocytes by the uridine phosphorylase inhibitors 5-benzylacyclouridine and 5-benzyloxybenzylacyclouridine. Lee KH; el Kouni MH; Chu HS; Cha S Cancer Res; 1984 Sep; 44(9):3744-8. PubMed ID: 6744292 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of uridine phosphorylase: synthesis and structure-activity relationships of aryl-substituted 5-benzyluracils and 1-[(2-hydroxyethoxy)methyl]-5-benzyluracils. Orr GF; Musso DL; Boswell GE; Kelley JL; Joyner SS; Davis ST; Baccanari DP J Med Chem; 1995 Sep; 38(19):3850-6. PubMed ID: 7562916 [TBL] [Abstract][Full Text] [Related]
14. 5-Benzylbarbituric acid derivatives, potent and specific inhibitors of uridine phosphorylase. Naguib FN; Levesque DL; Wang EC; Panzica RP; el Kouni MH Biochem Pharmacol; 1993 Oct; 46(7):1273-83. PubMed ID: 8216379 [TBL] [Abstract][Full Text] [Related]
15. Uridine phosphorylase inhibitors: chemical modification of benzyloxybenzyl-barbituric acid and its effects on urdpase inhibition. Guerin DJ; Mazeas D; Musale MS; Naguib FN; Al Safarjalani ON; el Kouni MH; Panzica RP Bioorg Med Chem Lett; 1999 Jun; 9(11):1477-80. PubMed ID: 10386920 [TBL] [Abstract][Full Text] [Related]
16. Phenylselenenyl- and phenylthio-substituted pyrimidines as inhibitors of dihydrouracil dehydrogenase and uridine phosphorylase. Goudgaon NM; Naguib FN; el Kouni MH; Schinazi RF J Med Chem; 1993 Dec; 36(26):4250-4. PubMed ID: 8277507 [TBL] [Abstract][Full Text] [Related]
17. Effect of administration of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on the anti-tumor efficacy of 5-fluoro-2'-deoxyuridine against murine colon tumor C26-10. Ashour OM; Naguib FN; Goudgaon NM; Schinazi RF; el Kouni MH Biochem Pharmacol; 2000 Sep; 60(5):687-92. PubMed ID: 10927027 [TBL] [Abstract][Full Text] [Related]
18. Uridine phosphorylase from Hymenolepis diminuta (Cestoda): kinetics and inhibition by pyrimidine nucleoside analogs. Drabikowska AK Acta Biochim Pol; 1996; 43(4):733-41. PubMed ID: 9104511 [TBL] [Abstract][Full Text] [Related]
19. Uridine phosphorylase from Schistosoma mansoni. el Kouni MH; Naguib FN; Niedzwicki JG; Iltzsch MH; Cha S J Biol Chem; 1988 May; 263(13):6081-6. PubMed ID: 3360774 [TBL] [Abstract][Full Text] [Related]
20. Acyclonucleoside analogues consisting of 5- and 5,6-substituted uracils and different acyclic chains: inhibitory properties vs purified E. coli uridine phosphorylase. Drabikowska AK; Lissowska L; Draminski M; Zgit-Wroblewska A; Shugar D Z Naturforsch C J Biosci; 1987 Mar; 42(3):288-96. PubMed ID: 2954322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]